iSBTc 24th Annual Meeting

October 29 - 31, 2009
Gaylord National Hotel and Convention Center
National Harbor, MD - Washington, D.C.

A record setting number of attendees converged in Washington, D.C. for the very successful iSBTc 24th Annual Meeting October 29-31, 2009 at the Gaylord National Hotel. Over 500 scientists, clinicians, students, fellows, researchers, and industry and regulatory representatives from 27 countries attended, shared cutting-edge science, and jointly celebrated the advancement and success of the immunotherapy/biological therapy field. There was much excitement among attendees centered on the high quality science, networking opportunities, and caliber of speakers and attendees present at the iSBTc 24th Annual Meeting.

Record Setting Year!

The iSBTc 24th Annual Meeting set several records including:

Program Attendance - over 500 attendees!
Countries Represented - people from 27 countries were in attendance.
Abstract Submissions - over 200 regular and late-breaking abstracts were submitted.
Young Investigator Award Candidates - over 100 abstracts submitted for consideration.

Topics Presented / Discussed

Adopt ive Transfer	Monoclonal Antibodies / Combinations
Clinical Trials of New Agents	Regulatory & Activated T Cell Subsets
Cytokines / Immunotherapy	Stem Cells / Circulating Tumor Cells
Enhancing Cancer Vaccines / Combinations	Targeted Therapeutics & Biological Therapy
Human Immunology	Viral & Cellular Proteomic Targets
Manipulation of the Tumor Microenvironment

Annual Meeting Organizers

Lieping Chen, MD, PhD Johns Hopkins University School of Medicince	Giorgio Trinchieri, MD National Cancer Institute
Robert Ferris, MD, PhD University of Pittsburgh Cancer Institute	Laurence Zitvogel, MD, PhD Institute Gustave Roussy
Carl H. June, MD University of Pennsylvania